If you were to experience serious side effects fevers, rash, vomiting, hives, blistering, muscle pain, or signs of an allergic reaction it would be best to stop using the peptide and contact your doctor immediately
Obesity 33 , 17251733 (2025)
it's a new logistics workflow for primary care
Consumer demand for Wegovy and Ozempic (semaglutide, from Novo Nordisk) created an FDA-official shortage, which temporarily allowed prescribers to work with compounding pharmacies and build weight management programs into their practices at a lower cost to consumers
In this case, the exclusivity for the diabetes indication could end in 2027, but for the obesity indication, it could be extended until 2030, assuming Lilly is granted the extra 3 years